36
1

ZMPCZM017000.10.03 Neuromove clinical presentation

Embed Size (px)

Citation preview

Page 1: ZMPCZM017000.10.03 Neuromove clinical presentation

1

Page 2: ZMPCZM017000.10.03 Neuromove clinical presentation

2

What is the NeuroMove?

It is an EMG Triggered Neurological Relearning tool for Stroke and other Brain Injury Paralysis Patients

Page 3: ZMPCZM017000.10.03 Neuromove clinical presentation

3

Stroke Patients

The number 1 cause of treatable paralysis

•Traumatic Brain Injury

•Spinal Cord Injury

•Palsy and other congenital paralysis relief

Who Benefits from

the NeuroMove

Page 4: ZMPCZM017000.10.03 Neuromove clinical presentation

4

Evidenced Based Successes

-Peer Reviewed Clinical Trialswww.neuromove.com

-Patient Testimonials

-Rehab Hospitals usage protocol

Page 5: ZMPCZM017000.10.03 Neuromove clinical presentation

5

Clinical Studies

Chronic Motor Dysfunction After Stroke

Conclusion: “Two lines of evidence clearly support the use of EMG triggered NMES treatment to rehabilitate wrist and fingers extension movements of hemipareticindividuals > 1 year after stroke…

Recovering Wrist and Finger Extension by EMG Triggered Neuromuscular stimulation. By James Caraugh, Ph.D

Page 6: ZMPCZM017000.10.03 Neuromove clinical presentation

6

Clinical Studies

“Progress often far exceeded that of

previous conventional therapy. Regarding mechanisms, impaired proprioceptive feedback is considered central to stroke-disrupted sensorimotor control. EMG-triggered EMS is intended to improve brain relearning by reinstating proprioceptive feedback time-locked to each attempted movement. Clinical results were consistent with this theory.”

See all clinical studies at www.neuromove.com

Page 7: ZMPCZM017000.10.03 Neuromove clinical presentation

7

U.S. FDA Cleared-For Stroke, TBI and SCI Rehabilitation-Relaxation of Muscle Spasms & Muscle Re-education-Prevention of Retardation of disuse atrophy-Increase Local Blood Circulation-Maintaining or Increasing Range of Motion

European Heath StandardsConformité Européene - CE

-Approved for – Stroke Recovery

Page 8: ZMPCZM017000.10.03 Neuromove clinical presentation

8

NeuroMovePrescribed by Leading Rehab HospitalsJohns Hopkins, MDTawam Hospital, UAE Cleveland Clinic Kennedy Krieger Intl. Spine Institute Rehab Institute of ChicagoMayo Clinic, MNKessler, NJMoss Magee Rehab, PAQueen Elizabeth, H.K.

St. John’s Mercy, St. LouisMt. Sinai, NYMarlton Rehab, NJMontefiore, Bronx, NYLutheran Hospital, Brooklyn, NYTIRR of HoustonMission Hospital, CALethbridge Hosp. CanadaTan Tok Seng, Singapore

Page 9: ZMPCZM017000.10.03 Neuromove clinical presentation

9

What Hospitals Say

about the NeuroMove

“…treatments are focused on patients who havehad a recent stroke as well as those who havesuffered from stroke-related disabilities for years.Lutheran's "Re-train the Brain" stroke recoveryprogram many long-suffering patients canregain long lost mobility and function.”

R. Ahmad, OTR, Director

Lutheran Rehab Network, Brooklyn, NY

Page 10: ZMPCZM017000.10.03 Neuromove clinical presentation

10

Acute Rehab

Out patient Rehab

Home Care Therapy

Page 11: ZMPCZM017000.10.03 Neuromove clinical presentation

11

Re Train the Brain Tools

Page 12: ZMPCZM017000.10.03 Neuromove clinical presentation

12

Neuroplasticity Stimulating the brain plasticity by driving the

healthy neurons to take over for damaged neurons thus regaining voluntary contractions

Patient imagines movement and is rewarded through stimulated muscle contraction…

MOVEMENT!

Page 13: ZMPCZM017000.10.03 Neuromove clinical presentation

13

What makes a Successful

Brain Relearning Tool?

Patient must be Cognitive

Engages the Brain

Intensive

Concentrated Effort

Frequency

Focused Repetition

Page 14: ZMPCZM017000.10.03 Neuromove clinical presentation

14

The Re-learning Tool - NeuroMove

EMG detects targeted neurological attempts to move the muscle

Utilizing Repetitive attempts and reward to stimulate Neural re-mapping

Page 15: ZMPCZM017000.10.03 Neuromove clinical presentation

15

Patients can experience immediate results.

Gives Stroke patients real hope and motivation

Page 16: ZMPCZM017000.10.03 Neuromove clinical presentation

16

Contraindications/Precautions

Implanted electrical devices

Cardiologist approval for use with pacemakers.

Epilepsy

Cancer Lesions

Use on Muscles only

Page 17: ZMPCZM017000.10.03 Neuromove clinical presentation

17

In the Kit

Electrode Placement Guide BookInstructional CDAC Cord for recharging3-Packs of 3-ElectrodesConnecting lead wireProgram Manual

Page 18: ZMPCZM017000.10.03 Neuromove clinical presentation

18

Therapy

Session Set-up

Attach electrodes muscle group

Turn on Unit.

Set e-stim to visible yet comfortable contraction

Page 19: ZMPCZM017000.10.03 Neuromove clinical presentation

19

Any Group of Muscles

Wrist & Finger Extension - Flexion

Front & Back Elbow Flexion

Shoulder Subluxation/Abduction

Ankle Dorsiflexion

Knee Extension

Starting points

upper or lower extremities

distally or proximally

Page 20: ZMPCZM017000.10.03 Neuromove clinical presentation

20

Ankle Dorsiflexion (Drop Foot)/Flexion

Red

Black

Red

Knee Extension - Front

Red

Red

Black

Red

Red

Black

Shoulder Subluxation/Abduction

Flexible: Use on anyMuscle Group

Refer to the Guide

Page 21: ZMPCZM017000.10.03 Neuromove clinical presentation

21

Therapy Session Overview

Cycle of TherapyRELAX: NM is Setting ThresholdREADY: Patient makes ATTEMPTGOOD: Stimulation or RewardRELAX: Deliberate rest

Page 22: ZMPCZM017000.10.03 Neuromove clinical presentation

22

RELAX

The processor begins to detect EMG and set the threshold

Threshold is adjusted up or down every 15 seconds Automatically

Page 23: ZMPCZM017000.10.03 Neuromove clinical presentation

23

READY Patient makes concentrated attempts

to make muscle exertion sensors detect real attempts.

Encourage the patient to imagine or visualize movement, have them close their eyes. Engage the brain!

Page 24: ZMPCZM017000.10.03 Neuromove clinical presentation

24

RewardImagination or attempt “strikes”

the threshold and triggers physical movement…the reward.

Page 25: ZMPCZM017000.10.03 Neuromove clinical presentation

25

Cycle is Repeated

The threshold is re-set every cycle and moves up or down to continually challenge or encourage the patient.

Page 26: ZMPCZM017000.10.03 Neuromove clinical presentation

26

NeuroMove Therapy Cycle

Hands On!

Page 27: ZMPCZM017000.10.03 Neuromove clinical presentation

27

NeuroMove Patients

Post stroke and SCI treatment may begin: Once stabilized Must be cognitive Up to 30 years post stroke Use at HOME

Treatment Time 15-60 Minutes each session Once a day building to 2 or 3 times a day Expect 4 months to a year treatment plan

Can be used with: Botox Baclofen Pump

Page 28: ZMPCZM017000.10.03 Neuromove clinical presentation

28

Other ApplicationsSpinal Cord Injury

*Set SCI Mode

Other Affliction ReliefErb’s Palsy

Bell’s Palsy

Cerebral Palsy

Multiple Sclerosis

Page 29: ZMPCZM017000.10.03 Neuromove clinical presentation

29

Ancillary Benefits of NM

High Quality NMES

Programmable Parameters

Treatment of Muscle Atrophy & Re-education

Muscle Spasms

Pain Relief

Page 30: ZMPCZM017000.10.03 Neuromove clinical presentation

30

Trouble Shooting

Signals

“check electrodes”

Clean skin and wet electrodes

Check for Broken lead wires

“Poor Signal on Graph”

Restart NM between muscle groups changes

Make sure Battery Charge is Full Charge

Set Default – See Program Guide

“EMG signal too low or too high”

Check SCI versus Stroke Rehab Mode .50/.25

Set Defaults and restart

Page 31: ZMPCZM017000.10.03 Neuromove clinical presentation

31

Program Settings

Set threshold to increase

or decrease challenge (can be set

during session)

Rest Period (default – 15 sec. Set:60

seconds)

Mode: Stroke & SCI

Set Audio On or Off

Compliance Data (number of sessions

and total time used)

Page 32: ZMPCZM017000.10.03 Neuromove clinical presentation

32

Program Settings

Change Parameterso Frequency and pulse width, ramp up/off timeo stim period (default at 5 sec.)

o Range: Can only be set when SCI Mode is selected

SCI two sensitivity ranges:o 0.25-25 uV

o 0.50-50 uV (use if signal is off screen w stroke patients)

Page 33: ZMPCZM017000.10.03 Neuromove clinical presentation

33

Is this like regular biofeedback?

No - Regular EMG (electromyography) may also have a very sensitive input, but for most other applications the input signals are filtered and averaged.

Some stroke survivors have no EMG activity or a strong muscle tone with high background “noise” - regular EMG/biofeedback will not stand a chance of detecting the changes that indicate a real attempt from the brain. The NeuroMove measures peak values in the EMG and has very fast input circuitry. Instead of averaging the input it does the opposite – it looks for a pattern in the small changes that indicate a real attempt. A very effective demonstration of this is when a non-patient actually

triggers the NeuroMove just by thinking about it and imagining a

movement

Page 34: ZMPCZM017000.10.03 Neuromove clinical presentation

34

Why only one channel?

It has one channel, patient must concentrate on one movement at a time

Is it like FES is an elaborate functional stimulation only. The patient can be watching TV and doing BioNess, but the brain will not relearn new pathways

Page 35: ZMPCZM017000.10.03 Neuromove clinical presentation

35

Is it complicated to set up?

No – Encourage Home-use.

Turn on the device and turn stimulation level up slowly for a comfortable contraction of the muscle

Think very hard about moving the fingers, wrist, shoulder, foot and other muscles

After relaxing, it returns to “Ready” and is ready for the next attempt, relaxing is as important as concentrating

Page 36: ZMPCZM017000.10.03 Neuromove clinical presentation

36

Hands on Therapy Session